Sutro Biopharma (STRO) PT Lowered to $34 at Citizens on Q2 Revenue Miss

August 13, 2026 4:13 AM

Citizens analyst Reni Benjamin lowered the price target on Sutro Biopharma (NASDAQ: STRO) to $34.00 (from $41.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found